British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Emerg Infect Dis. 2010 Feb;16(2):251-7. doi: 10.3201/eid1602.090900.
British Columbia, Canada, has the largest reported population of Cryptococcus gattii-infected persons worldwide. To assess the impact of illness, we retrospectively analyzed demographic and clinical features of reported cases, hospitalizations, and deaths during 1999-2007. A total of 218 cases were reported (average annual incidence 5.8 per million persons). Most persons who sought treatment had respiratory illness (76.6%) or lung cryptococcoma (75.4%). Persons without HIV/AIDS hospitalized with cryptococcosis were more likely than those with HIV/AIDS to be older and admitted for pulmonary cryptococcosis. The 19 (8.7%) persons who died were more likely to be older and to have central nervous system disease and infection from the VGIIb strain. Although incidence in British Columbia is high, the predominant strain (VGIIa) does not seem to cause greater illness or death than do other strains. Further studies are needed to explain host and strain characteristics for regional differences in populations affected and disease outcomes.
加拿大不列颠哥伦比亚省拥有全世界报道的感染隐球菌人数最多。为了评估疾病的影响,我们回顾性分析了 1999 年至 2007 年期间报告的病例、住院和死亡的人口统计学和临床特征。共报告了 218 例病例(平均年发病率为每百万人 5.8 例)。大多数接受治疗的患者患有呼吸道疾病(76.6%)或肺部隐球菌瘤(75.4%)。没有艾滋病毒/艾滋病的隐球菌病住院患者比有艾滋病毒/艾滋病的患者更有可能年龄较大,并因肺部隐球菌病入院。19 名(8.7%)死亡的患者更有可能年龄较大,并患有中枢神经系统疾病和 VGIIb 株感染。尽管不列颠哥伦比亚省的发病率很高,但主要菌株(VGIIa)似乎不会比其他菌株引起更严重的疾病或死亡。需要进一步的研究来解释受影响人群和疾病结局的宿主和菌株特征的区域差异。